Last reviewed · How we verify
Heparin and protamine titration
At a glance
| Generic name | Heparin and protamine titration |
|---|---|
| Sponsor | SANE-Society of Anesthesiology |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Coagulation in Acute Aortic Dissection (NA)
- Anticoagulation Management in Complex Cardiac Surgery (PHASE4)
- Heparin and Protamine Titration in Cardiac Surgery Under Minimal Invasive Extracorporeal Circulation (NA)
- Cardiac Surgery: In Vivo Titration of Protamine (NA)
- Clinical Trial Comparing Heparin and Protamine Fixed and Titrated Doses in Cardiac Surgery With Cardiopulmonary Bypass (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Heparin and protamine titration CI brief — competitive landscape report
- Heparin and protamine titration updates RSS · CI watch RSS
- SANE-Society of Anesthesiology portfolio CI